Experience

Reviva Pharmaceuticals

• United States
• Biotechnology Research
• 1 - 100 Employee

• Member, Board of Directors

  • Dec 2020 - Present



CNS Research Solutions LLC

• Cambridge, Massachusetts USA

• Founder and Principal Consultant

  • May 2018 - Present

  *Consultancy supporting development of novel therapeutics for CNS disorders, especially neurodegenerative diseases *Expertise: translational neuroscience, including imaging and fluid biomarkers; clinical pharmacology; development strategy; and clinical trial design and execution (Phase 1-4) *Consultancy supporting development of novel therapeutics for CNS disorders, especially neurodegenerative diseases *Expertise: translational neuroscience, including imaging and fluid biomarkers; clinical pharmacology; development strategy; and clinical trial design and execution (Phase 1-4)



TauC3 Biologics Ltd.

• London, England, United Kingdom

• Senior Vice President, Translational Sciences and Clinical Development

  • Feb 2020 - Present



Eikonizo Therapeutics

• United States
• Biotechnology
• 1 - 100 Employee

• Chief Medical Officer

  • Jan 2020 - Present



Pfizer

• United States
• Pharmaceutical Manufacturing
• 700 & Above Employee

• Executive Director, Clinical Neuroscience

  • Dec 2016 - Apr 2018

  Interim Clinical Group Head, Alzheimer's Disease, Internal Medicine Research Unit. Clinical development guidance for discovery teams and clinical oversight of mutiple early stage clinical trials. Interim Clinical Group Head, Alzheimer's Disease, Internal Medicine Research Unit. Clinical development guidance for discovery teams and clinical oversight of mutiple early stage clinical trials.



CereSpir, Inc.

• Greater New York City Area

• Vice President, Clinical Development

  • Nov 2013 - Dec 2016

  Direct clinical development for a biotech company developing disease-modifying treatments for Alzheimer's disease and other neurodegenerative disorders. Direct clinical development for a biotech company developing disease-modifying treatments for Alzheimer's disease and other neurodegenerative disorders.



JANSSEN Alzheimer Immunotherapy

• San Francisco Bay Area

• Senior Director, Biomarkers

  • May 2011 - Nov 2013

  Biomarker research in the study of immunotherapeutic treatments for Alzheimer's disease. Biomarker research in the study of immunotherapeutic treatments for Alzheimer's disease.



Merck

• United States
• Pharmaceutical Manufacturing
• 700 & Above Employee

• Director, Clinical Pharmacology

  • Jan 2008 - May 2011

  Translational neuroscience; Phase 1 studies. Biomarkers, esp. Imaging. I was part of the Schering-Plough organization (Early Clinical Research and Experimental Medicine) prior to the merger. Translational neuroscience; Phase 1 studies. Biomarkers, esp. Imaging. I was part of the Schering-Plough organization (Early Clinical Research and Experimental Medicine) prior to the merger.



i3 Research

• Pharmaceutical Manufacturing
• 200 - 300 Employee

• Vice President and Global Head, CNS

  • 2005 - 2008

  Initially Senior Director, CNS (North America). My position involved direction and development of the CNS scientific group (neurologists and psychiatrists) involved in the conduct of Phase 2/3 trials, as well as advancement of the CNS capabilities of the company more generally. Initially Senior Director, CNS (North America). My position involved direction and development of the CNS scientific group (neurologists and psychiatrists) involved in the conduct of Phase 2/3 trials, as well as advancement of the CNS capabilities of the company more generally.



University of Southern California

• United States
• Higher Education
• 700 & Above Employee

• Visiting Professor and Director, Division of Consultation-Liaison Psychiatry

  • Sep 2000 - Jun 2005



Vanderbilt University Medical Center

• United States
• Hospitals and Health Care
• 700 & Above Employee

• Associate Professor and Director, Laboratory of Geriatric Neuroscience

  • 1997 - 2001



National Institutes of Health

• Medical Staff Fellow

  • 1982 - 1984